Literature DB >> 25142788

[Organ and kidney function preservation in renal cell carcinoma].

M Schenck1, R Eder, H Rübben, C Niedworok, S Tschirdewahn.   

Abstract

BACKGROUND: The organ-preserving partial nephrectomy has increasingly established itself in small unilateral renal tumours (<4 cm) with contralateral healthy kidney and counter gained in recent years in importance. There was found a significantly increased cardiovascular mortality rate and deteriorated quality of life, the more intact kidney tissue has been removed.
OBJECTIVES: In the present study, the influence of pre- and perioperative factors on direct postoperative course was examined, including 5-year survival rate and relapse behaviour after open organ-preserving partial nephrectomy in our own collective.
MATERIALS AND METHODS: In this retrospective study of 1657 patients were collected, who underwent surgery between 2007 and 2013 in the Department of Urology at the University Hospital Essen because of a renal tumour. 38 % of these operations (n = 636) were performed organ-preserving. In this trial there are factors identified that have an impact on need of blood transfusion and length of hospitalization in organ-preserving operation method.
RESULTS: No independent parameter can be determined for the need of blood transfusion. Tumour size and thus time of resection procedure does not affect the need of erythrocytes administration. In addition, the tumour size influences neither the postoperative serum-haemoglobin nor serum-creatinine. Increased patient age and female gender are identified as non-modifiable factors, which cause a longer hospitalisation. Postoperative pain therapy can be considered as a variable size, which does not affect the length of hospital stay. Modifiable factors that increase the overall length of stay, however, are the type of direct postoperative monitoring (ICU vs. anaesthetic recovery room) and the administration of blood transfusions.
CONCLUSIONS: There are constant factors, which can be associated with a longer residence time in the framework of an organ-preserving partial nephrectomy. Further there is shown evidence of the independence of the tumour size - in addition to proven good oncological results - of an extension of indication of organ-preserving nephrectomy of tumours > 4 cm.

Entities:  

Mesh:

Year:  2014        PMID: 25142788     DOI: 10.1007/s00120-014-3558-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  61 in total

1.  Rethinking staging and treatment for renal cell cancer.

Authors:  S J Freedland; D Chao; A J Pantuck; A Zisman; A S Belldegrun
Journal:  Rev Urol       Date:  2001

Review 2.  Renal cell carcinoma: vena caval involvement.

Authors:  Stephen A Boorjian; Shomik Sengupta; Michael L Blute
Journal:  BJU Int       Date:  2007-05       Impact factor: 5.588

3.  A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Authors:  Bradley C Leibovich; John C Cheville; Christine M Lohse; Horst Zincke; Igor Frank; Eugene D Kwon; Jaime R Merchan; Michael L Blute
Journal:  J Urol       Date:  2005-11       Impact factor: 7.450

Review 4.  Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector ct and three-dimensional CT.

Authors:  S Sheth; J C Scatarige; K M Horton; F M Corl; E K Fishman
Journal:  Radiographics       Date:  2001-10       Impact factor: 5.333

5.  Family history and risk of renal cell carcinoma.

Authors:  M Gago-Dominguez; J M Yuan; J E Castelao; R K Ross; M C Yu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-09       Impact factor: 4.254

6.  Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma.

Authors:  Christian Gratzke; Michael Seitz; Florian Bayrle; Boris Schlenker; Patrick J Bastian; Niko Haseke; Markus Bader; Derya Tilki; Alexander Roosen; Alexander Karl; Oliver Reich; Wael Y Khoder; Stephen Wyler; Christian G Stief; Michael Staehler; Alexander Bachmann
Journal:  BJU Int       Date:  2009-02-23       Impact factor: 5.588

7.  Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Peter R Mueller; Chin Hur; G Scott Gazelle
Journal:  Radiology       Date:  2008-05-05       Impact factor: 11.105

8.  Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma.

Authors:  Matthias May; Sabine Brookman-Amissah; Friederike Kendel; Nina Knoll; Jan Roigas; Bernd Hoschke; Kurt Miller; Christian Gilfrich; Sandra Pflanz; Oliver Gralla
Journal:  Int J Urol       Date:  2009-05-13       Impact factor: 3.369

Review 9.  [Classification of renal cell carcinoma/tumors and their relationship to the nephron-collecting tubules system].

Authors:  W Thoenes; H J Rumpelt; S Störkel
Journal:  Klin Wochenschr       Date:  1990-11-16

10.  Epidemiology of kidney cancer.

Authors:  D Pascual; A Borque
Journal:  Adv Urol       Date:  2008-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.